NCT03108521View on ClinicalTrials.gov

SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients)

PHASE4CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

April 21, 2016

Primary Completion Date

January 4, 2018

Study Completion Date

October 8, 2018

Conditions
Diabetes Mellitus
Interventions
DRUG

Sitagliptin

100mg.QD for 3 months

Trial Locations (1)

610000

Sichuan provincial people's hospital, Chengdu

All Listed Sponsors
lead

Sichuan Provincial People's Hospital

OTHER

NCT03108521 - SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients) | Biotech Hunter | Biotech Hunter